How Some Bone Marrow/Stem Cell Transplants Can Lead to Complications
Corey Cutler, MD, MPH, FRCPC, Medical Director, Stem Cell Transplant Program, Dana-Farber Cancer Institute and Vice President, American Society for Tran...
5347 articles
Corey Cutler, MD, MPH, FRCPC, Medical Director, Stem Cell Transplant Program, Dana-Farber Cancer Institute and Vice President, American Society for Tran...
Ryan Case, PhD, Head of Clinical Medical Affairs at Neuroderm, a Mitsubishi Tanabe Pharma Corporation (MTPC), discusses the highly positive results from...
Lisa Yañez, CEO of Aerami Therapeutics, a clinical-stage biopharmaceutical company dedicated to breathing life into the treatment of serious cardiopulm...
Rakesh Suri, President and Chief Medical Officer at Fountain Life, a preventative health and longevity company discusses Fountain Life's unique data-dri...
Medical Advisor, Drug Monitoring and Toxicology at Quest Diagnostics discusses a report that he co-authored that found that one in two patients (49%) sh...
Derek Wallace, MBBS, Vice President and Global Dengue Program Head at Takeda discusses the dengue program and the European Commission (EC) approval of t...
Holly Johnson, Director of Medical Information at Myriad Mental Health discusses the GeneSight test that analyzes genes to see how a person may respond ...
Graft-versus-host disease, also known as GVHD, is a life-threatening condition that can occur after an allogeneic stem cell transplant, or the transfer ...
Antonio Anzueto, Professor of Medicine and Section Chief of Pulmonary at South Texas Veterans Healthcare System, an affiliated Institution with the Univ...
Sangamo Therapeutics is working to translate groundbreaking science into genomic cures. Learn more on Health Professional Radio.